An exploratory, randomized, double blind, placebo controlled, parallel groups Phase II clinical trial to evaluate the efficacy and safety of E-52862 (400 mg) by oral route, in patients with painful diabetic neuropathy.
Phase of Trial: Phase II
Latest Information Update: 30 Sep 2016
At a glance
- Drugs E 52862 (Primary)
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Proof of concept; Therapeutic Use
- Sponsors Laboratorios Dr. Esteve
- 30 Sep 2016 Results of this study, presented at the 16th World Congress on Pain.
- 07 Feb 2015 Status changed from recruiting to completed, according to European Clinical Trials Database record.
- 06 Jul 2012 New trial record
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History